NMXS (Net Medical Xpress Solutions) Cyclically Adjusted Revenue per Share: $ (As of Mar. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Net Medical Xpress Solutions Cyclically Adjusted Revenue per Share?

Net Medical Xpress Solutions NMXS +0.14% Cyclically Adjusted Revenue per Share is $ as of Mar. 2024.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Net Medical Xpress Solutions's adjusted revenue per share for the three months ended in Mar. 2024 was $0.000. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $ for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-09-20), Net Medical Xpress Solutions's current stock price is $0.0007. Net Medical Xpress Solutions's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $. Net Medical Xpress Solutions's Cyclically Adjusted PS Ratio of today is .


Net Medical Xpress Solutions  (OTCPK:NMXS) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Net Medical Xpress Solutions Cyclically Adjusted Revenue per Share Related Terms


Net Medical Xpress Solutions Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Net Medical Xpress Solutions's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Net Medical Xpress Solutions Cyclically Adjusted Revenue per Share Chart

Net Medical Xpress Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Net Medical Xpress Solutions Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NMXS vs TVMD, UCBB, ESSI: Cyclically Adjusted Revenue per Share Comparison

For the Health Information Services subindustry, Net Medical Xpress Solutions's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Net Medical Xpress Solutions Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Net Medical Xpress Solutions's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Net Medical Xpress Solutions's Cyclically Adjusted PS Ratio falls into.



Net Medical Xpress Solutions Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Net Medical Xpress Solutions's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/312.3320*312.3320
=0.000

Current CPI (Mar. 2024) = 312.3320.

Net Medical Xpress Solutions Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.063 238.343 0.083
201409 0.059 238.031 0.077
201412 0.054 234.812 0.072
201503 0.062 236.119 0.082
201506 0.056 238.638 0.073
201509 0.049 237.945 0.064
201512 0.043 236.525 0.057
201603 0.047 238.132 0.062
201606 0.043 241.018 0.056
201609 0.034 241.428 0.044
201612 0.033 241.432 0.043
201703 0.038 243.801 0.049
201706 0.034 244.955 0.043
201709 0.032 246.819 0.040
201712 0.040 246.524 0.051
201803 0.025 249.554 0.031
201806 0.027 251.989 0.033
201809 0.030 252.439 0.037
201812 0.024 251.233 0.030
201903 0.019 254.202 0.023
201906 0.016 256.143 0.020
201909 0.019 256.759 0.023
201912 0.017 256.974 0.021
202003 0.015 258.115 0.018
202006 0.010 257.797 0.012
202009 0.009 260.280 0.011
202012 0.009 260.474 0.011
202103 0.010 264.877 0.012
202106 0.010 271.696 0.011
202109 0.010 274.310 0.011
202112 0.024 278.802 0.027
202203 0.051 287.504 0.055
202206 0.040 296.311 0.042
202209 0.027 296.808 0.028
202212 0.019 296.797 0.020
202303 0.006 301.836 0.006
202306 0.004 305.109 0.004
202309 0.004 307.789 0.004
202312 0.002 306.746 0.002
202403 0.000 312.332 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $ mean?
Net Medical Xpress Solutions (NMXS) has a Cyclically Adjusted Revenue per Share of $ as of Mar. 2024. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Net Medical Xpress Solutions and its competitors.
Is Net Medical Xpress Solutions' Cyclically Adjusted Revenue per Share too high?
Net Medical Xpress Solutions' current Cyclically Adjusted Revenue per Share is $.
How does Net Medical Xpress Solutions' Cyclically Adjusted Revenue per Share compare to TVMD and UCBB?
Net Medical Xpress Solutions' Cyclically Adjusted Revenue per Share of $ can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Net Medical Xpress Solutions and its competitors. Net Medical Xpress Solutions's current Cyclically Adjusted Revenue per Share is $. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Net Medical Xpress Solutions stock overvalued right now?
Net Medical Xpress Solutions (NMXS) has a current Cyclically Adjusted Revenue per Share of $. The current Cyclically Adjusted Revenue per Share is $. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Net Medical Xpress Solutions (NMXS), the current Cyclically Adjusted Revenue per Share is $ as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Net Medical Xpress Solutions Business Description

Address 8206 Louisiana Boulevard NE, Suite A, Albuquerque, NM, USA, 87113
Net Medical Xpress Solutions Inc is engaged in providing solutions to the telemedicine industry which deliver medical laboratory services. It offers proprietary software that links electronic medical records while enabling state-of-the-art conferencing and communications. The company's mobile fleet of vans is utilized to provide sales support for its clinical research organization. It also offers call centers, proprietary hardware implementations, diagnostic and clinical services, and software research and development capabilities.